The Cancer Letter

Inside information on cancer research and drug development

In Brief

Kristin Brill named enterprise director of Breast Oncology at SKCC

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Breast surgeon Kristin L. Brill has joined the Sidney Kimmel Cancer Center–Jefferson Health as enterprise director of Breast Oncology.

Particular areas of focus for Brill include young women with breast cancer and those at high risk.

Brill joins SKCC from Cooper University Health Care, where she was head of the Division of Breast Surgery and Director of the Janet Knowles Breast Cancer Center at MD Anderson Cancer Center at Cooper and assistant professor of surgery at Cooper Medical School of Rowan University. She also directed the Breast Surgical Oncology Fellowship at Cooper Medical School and was an adjunct assistant professor in the Department of Surgery at MD Anderson Cancer Center.

Table of Contents

YOU MAY BE INTERESTED IN

Cancer History ProjectGuest Editorial

At Lung SPORE Workshop, experts reflect on the significance of discovery of EGFR mutations two decades ago

Twenty years ago, the discovery of epidermal growth factor receptor mutations as drivers of tumorigenesis and viable targets for therapeutic intervention marked the beginning of a new era in lung cancer diagnosis and treatment. Since then, the field has made remarkable progress towards developing more effective targeted treatments and immunotherapies that have significantly improved patient outcomes and survival.
By Katerina A. Politi and Roy S. Herbst
Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account